Date: 2015-10-27
Type of information: Nomination
Compound:
Company: iDD Biotech (France)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On October 27, 2015, iDD Biotech announced it has appointed Paul Michalet as Chairman of the Management
Board. Paul Michalet has held a number of senior executive positions in the last 25 years. He had various responsibilities in finance for 10 years in manufacturing and service industries and, in the past 15 years, he held senior executive positions in biotechnology companies active in the chemical and cosmetics industries. He was most recently CFO in charge of the strategy and the business development of Fermentalg, a listed industrial biotech company listed in Compartment
C of Eurolist Paris. During his various senior positions, Paul Michalet negotiated several important license
agreements and he achieved cumulative fund raising of over € 200m, including 3 successful IPOs: Fermentalg in 2014, METabolicEXplorer in 2007 and Coletica in 2000 (today BASF Beauty Care Solutions)
Paul Michalet is a graduate from ESC Montpelier business school. He is a member of the DFCG (France’s Finance Executives association) and the SFAF (France Society of Financial Analysts) and sits as an independent Director at the supervisory board of Biofilm-Control.
iDD biotech alwo strengthened its governance by adopting a Supervisory Board and a Management Board to conduct the company’s new phase of growth:
- Jean-Pierre Lehner becomes Chairman of the Supervisory Board and Hélène Rouquette Vice-President.
- Paul Michalet becomes Chairman of the Management Board, and will also lead finance, business development and Claudine Vermot-Desroches, Vice-President, in charge of R&D.
Financial terms:
Latest news:
